ProCE Banner Activity

Current Clinical Experience and New Therapeutic Directions for Second-line and Subsequent Lines of Therapy

Slideset Download
Download these slides from a live Webinar to gain expert insight on the optimal treatment options for patients with metastatic urothelial cancer who are experiencing disease progression, including the latest evidence from ASCO GU 2021.

Released: February 22, 2021

Expiration: February 21, 2022

No longer available for credit.

Share

Faculty

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania